资讯

The latest results from a trial of a pill form popular GLP-1 medications offer enough information for the Eli Lilly to ...
GLP-1 pill may help people with Type 2 diabetes lose 'significant' weight, study says Drug manufacturer Eli Lilly releases promising new data about its weight loss pill in clinica ...
New data from Eli Lilly says its daily, oral GLP-1 pill may help people who have obesity and people who have Type 2 diabetes lose a significant amount of weight.
With around 73 percent of Americans enjoying their daily coffee fix, it’s natural to wonder how your morning cup might ...
The results of the ATTAIN-2 study, which involved people with obesity or overweight and type 2 diabetes, showed that the oral ...
Eli Lilly said its once-daily weight loss pill was effective for people with obesity and type 2 diabetes in a key trial, ...
The TV presenter, 58, shared her concerns for 'impressionable young women' and said the endorsement was a 'betrayal of ...
A groundbreaking final stage trial showed users could lose more than 10 per cent of their weight after just over a year on ...
Eli Lilly (NYSE:LLY) announced on Tuesday that its oral weight loss therapy, orforglipron, reached the main goals in a second ...
Eli Lilly stated that results from a late-stage trial of its pill variant of GLP-1 drugs met the requirements for global ...
A growing number of patients claim popular weight loss and diabetes drugs like Ozempic can cause a rare but very serious side ...